Researchers have also reported that METTL3-mediated M6A modification can decrease ANGPTL3 mRNA levels and that the inhibitory effects of METTL3 silencing on cancer progression can be partially reversed by ANGPTL3 inhibition. This evidence concerns the gene METTL3 and cancer.